Natalia Soledad Ogonowski

Dr. Natalia Soledad Ogonowski


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Genes
Verified
Journal Article
Open access
PDF file
VFVictor Flores-Ocampo
Victor Flores-Ocampo
ALAmanda Wei Yin Lim
Amanda Wei Yin Lim
NONatalia Soledad Ogonowski
Natalia Soledad Ogonowski
LGLuis M. García-Marín
Luis M. García-Marín
JOJue-Sheng Ong
Jue-Sheng Ong
MRMiguel E. Rentería
Miguel E. Rentería
Background: Parkinson’s disease (PD) is a genetically complex neurodegenerative disorder. Up to 15% of cases are considered monogenic. However, research on monogenic PD has largely focused on populations of European ancestry, leaving gaps in our understanding of genetic variability in other populations. This study addresses this gap by analysing the allele frequencies of pathogenic and likely pathogenic variants in known monogenic PD genes across eight global populations, using data from the gnomAD database. Methods: We compiled a list of 27 genes associated with Mendelian PD from the Online Mendelian Inheritance in Man (OMIM) database, and identified pathogenic and likely pathogenic variants using ClinVar. We then performed pairwise comparisons of allele frequencies across populations included in the gnomAD database. Variants with significant frequency differences were further assessed using in silico pathogenicity predictions. Results: We identified 81 variants across 17 genes with statistically significant allele frequency differences between at least two populations. Variants in GBA1 were the most prevalent among monogenic PD-related genes, followed by PLA2G6, ATP13A2, VPS13C, and PRKN. GBA1 exhibited the greatest variability in allele frequencies, particularly the NM_000157.4:c.1226A>G (p.Asn409Ser) variant. Additionally, we observed significant population-specific differences in PD-related variants, such as the NM_032409.3:c.1040T>C (p.Leu347Pro) variant in PINK1, which was most prevalent in East Asian populations. Conclusions: Our findings reveal substantial population-specific differences in the allele frequencies of pathogenic variants linked to monogenic PD, emphasising the need for broader genetic studies beyond European populations. These insights have important implications for PD research, genetic screening, and understanding the pathogenesis of PD in diverse populations.

22 October 2026 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
VFVictor Flores-Ocampo
Victor Flores-Ocampo
GSGrecia Sevilla-Parra
Grecia Sevilla-Parra
FCFangyuan Cao
Fangyuan Cao
DDDeepak Darshan
Deepak Darshan
SDSantiago Díaz-Torres
Santiago Díaz-Torres
NONatalia Soledad Ogonowski
Natalia Soledad Ogonowski
Introduction: Compound heterozygous (CH) genotypes represent an established biallelic autosomal-recessive mechanism in early-onset Parkinson’s disease (EOPD), whereas digenic inheritance (DI) has been proposed for variant combinations across two genes but is more difficult to establish. We systematically evaluated the genetic architecture and clinical features of CH cases and cases reported as DI in the published literature. Methods: This PRISMA-compliant systematic review included studies reporting CH or DI EOPD through September 2026. Two reviewers independently screened studies, extracted data, and curated variant- and case-level information. Variants were harmonized using current Human Genome Variation Society nomenclature and classified by gene, variant type, ancestry, and inheritance model. Results: We included 106 studies comprising 304 CH and 16 DI cases. CH was dominated by PRKN , with structural variants present in 85% (205/241) of PRKN cases, predominantly exon-level deletions. PINK1 was the second most frequently implicated CH gene, whereas other CH subtypes were rare and genetically heterogeneous. Cases reported as DI involved seven genes, most commonly LRRK2 – PRKN and PINK1 – PRKN , although most variant combinations were unique. Across the CH and reported-DI groups, patients presented with a core Parkinsonian syndrome but showed substantial variability in age at onset, motor severity, and non-motor manifestations. PRKN -associated CH cases generally had earlier onset and favorable levodopa responsiveness, whereas PLA2G6 - and VPS13C -associated cases more often exhibited cognitive impairment, psychiatric features, or structural neuroimaging abnormalities. No reproducible genotype-specific phenotype emerged. Conclusion: Compound heterozygous represents a conventional biallelic recessive mechanism in EOPD and was largely driven by PRKN structural variation. In contrast, cases reported as DI were rare and heterogeneous, and the available evidence generally did not establish causal digenic inheritance. These findings support comprehensive detection of structural and sequence variants while highlighting the need for segregation, functional, and replication evidence to distinguish causal DI from modifier effects or coincidental variant co-occurrence.